An Open Label, Randomized-controlled Trial to Assess Efficacy Safety of HYALODISC With Physical Exercise Program

NAUnknownINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

December 1, 2024

Conditions
Degenerative Disc Disease(DDD)
Interventions
DEVICE

Intradiscal injection

The injection will be administered at V1 baseline (day 0). Any physical activity (e.g. jogging, tennis, weightlifting, prolonged upright position) in the 48 hours following the injection should be avoided.

Trial Locations (2)

09123

RECRUITING

Unità operativa complessa di Radiologia PO.SS.Trinità, Cagliari

CH-6962

RECRUITING

Centro per la Terapia del Dolore NSI-EOC FMH Anestesiologia S.S.I.P.M.. Ospedale, Viganello

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY